Cloud-based software solutions provider ArisGlobal has introduced LifeSphere CTMS10, an end-to-end solution that makes the entire clinical trial management process easier.
ArisGlobal said that companies of all sizes will benefit from a more transparent, simplified, and efficient clinical trial management process with the new solution.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
LifeSphere CTMS10 enables life sciences organisations to track and control all trial set-up, as well as conduct and closeout activities using a simple interface designed to offer global oversight and visibility.
Unlike other clinical trial management system (CTMS) applications, LifeSphere CTMS10 comprises payments and monitoring modules out-of-the-box to ensure faster and accurate disbursements to research sites.
The solution also maximises CRA effectiveness in the field.
ArisGlobal Clinical Product Management senior director Sondra Pepe said: “Trials have grown in cost and complexity, and it is increasingly difficult for teams to manage stakeholders, maintain oversight, and meet tight timelines.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“LifeSphere CTMS10 was designed to solve these challenges through simplicity and an all-in-one approach that includes everything an organization needs to run an efficient, streamlined trial out-of-the-box.”
LifeSphere CTMS10 automates core activities, such as study planning, site assessments, investigator selection, enrolment planning, and site visit planning, allowing clinical teams be more efficient and conduct trials at a faster pace.
LifeSphere CTMS10 is part of the unified LifeSphere Clinical Cloud platform, which includes LifeSphere eTMF and LifeSphere EDC.
According to the company, it seamlessly connects clinical operations with data management in order to give full visibility and control over trial execution to the clinical teams.
